Danaher Stock Is Down 19% In the Past 3 Months. Could DHR Reach $248?

Danaher Corporation (DHR) shows signs of recovery with a 3.5% revenue increase in Q1 2026 and raised EPS guidance, primarily driven by improving bioprocessing demand. The article’s valuation model suggests DHR could reach $248 per share by late 2028, representing a 27% total return from its current price, based on assumptions of 6% annual revenue growth, 30% operating margins, and a 23x P/E multiple. This analysis considers the impact of the recent Masimo acquisition and the need for steady core growth and effective integration.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin